Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 245 publications
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China.
Journal: Cephalalgia : an international journal of headache
Published: October 09, 2025
A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine.
Journal: Cephalalgia : an international journal of headache
Published: July 30, 2025
Structure-guided drug repurposing and dynamics simulation reveal anti-viral candidates for Bourbon virus.
Journal: In silico pharmacology
Published: July 30, 2025
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data.
Journal: Cephalalgia : an international journal of headache
Published: July 28, 2025
Bridging CGRP mAbs with Gepants: An innovative approach to address the wearing-off phenomenon.
Journal: Clinical neurology and neurosurgery
Published: July 25, 2025
Rimegepant safety and patient-reported outcomes among triptan-naïve, triptan-using, and triptan-failure participants: Subgroup analysis of an open-label, multicenter study.
Journal: Cephalalgia : an international journal of headache
Published: July 09, 2025
Exposure Matching Using Population Pharmacokinetic Modeling and Simulation to Support Rimegepant Dose Selection for Pediatric Patients With Migraine.
Journal: Clinical and translational science
Published: June 16, 2025
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trials.
Journal: Postgraduate medicine
Published: June 10, 2025
Exploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report.
Journal: Journal of drugs in dermatology : JDD
Published: June 04, 2025
Last Updated: 10/31/2025